BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,228,063 | +59.2% | 2,511,180 | +3.8% | 0.01% | +60.0% |
Q2 2023 | $41,613,175 | +11.4% | 2,419,370 | +7.4% | 0.01% | 0.0% |
Q1 2023 | $37,357,371 | +237210.2% | 2,253,158 | +9.1% | 0.01% | +150.0% |
Q4 2022 | $15,742 | -99.9% | 2,065,907 | +5.2% | 0.00% | -33.3% |
Q3 2022 | $19,520,000 | +9.1% | 1,963,877 | -0.3% | 0.00% | 0.0% |
Q2 2022 | $17,891,000 | -1.2% | 1,970,446 | +10.4% | 0.00% | +50.0% |
Q1 2022 | $18,113,000 | -43.7% | 1,784,576 | -7.4% | 0.00% | -50.0% |
Q4 2021 | $32,149,000 | -64.8% | 1,927,411 | -1.0% | 0.00% | -66.7% |
Q3 2021 | $91,259,000 | -17.9% | 1,947,085 | +6.8% | 0.01% | -20.0% |
Q2 2021 | $111,187,000 | +8.5% | 1,823,938 | +9.7% | 0.02% | -6.2% |
Q1 2021 | $102,438,000 | +19.1% | 1,662,957 | +37.5% | 0.02% | +14.3% |
Q4 2020 | $86,023,000 | +97.9% | 1,209,721 | +4.4% | 0.01% | +55.6% |
Q3 2020 | $43,472,000 | +81.9% | 1,158,655 | +58.1% | 0.01% | +80.0% |
Q2 2020 | $23,901,000 | +14.0% | 732,935 | +1.4% | 0.01% | 0.0% |
Q1 2020 | $20,959,000 | -13.9% | 722,737 | +4.0% | 0.01% | +66.7% |
Q4 2019 | $24,350,000 | +238.1% | 694,756 | +107.1% | 0.00% | +50.0% |
Q3 2019 | $7,202,000 | – | 335,448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |